64 results on '"Chen, Pei-Jer"'
Search Results
2. Targeting histone deacetylase 4/ubiquitin‐conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice
3. Metastatic tumor antigen 1 contributes to hepatocarcinogenesis posttranscriptionally through RNA‐binding function
4. Mapping the conformational epitope of a therapeutic monoclonal antibody against HBsAg by in vivo selection of HBV escape variants
5. Hepatitis C Viral Infection Increases the Risk of Lymphoid-Neoplasms: A Population-Based Cohort Study
6. Development of Risk Scoring System for Stratifying Population for Hepatocellular Carcinoma Screening
7. Analysis of innate and adaptive host immunity during combination therapy with peginterferon Lambda-1a and Entecavir in patients with HBeAg(+) chronic hepatitis B: 219
8. Patients with chronic hepatitis C virus infection have an increased risk of non-Hodgkinʼs lymphoma: 173
9. Strategy for preventing hepatitis B reactivation in patients with resolved hepatitis B virus infection after rituximab-containing chemotherapy
10. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study
11. Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma
12. Cell‐Free Virus‐Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer
13. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up
14. Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion
15. Serum Hepatitis B Surface Antigen Levels Help Predict Disease Progression in Patients With Low Hepatitis B Virus Loads
16. Observations of Hepatocellular Carcinoma (HCC) Management Patterns from the Global HCC BRIDGE Study: Global Comparison of Outcomes by Locoregional Therapy: 1940
17. Peginterferon alfa-2a plus Low Dose Ribavirin versus Peginterferon alfa-2a Monotherapy for Dialysis Patients with Hepatitis C Virus Genotype 1 Infection: A Randomized Trial: 1722
18. IL28B polymorphisms predict hepatic steatosis in Taiwanese HCV genotype 1 patients: 948
19. Young Nucleos(t)ide Analogues-induced Hepatitis B e Antigen Seroconverters Have a Higher Risk of HBV Reactivation: 924
20. Presence of serum HBV RNA predicts initial virological response in nucleoside analogue treated chronic hepatitis B patients: 470
21. HBV genotype B patients have more serum and intrahepatic HBsAg decline following interferon therapy than genotype C patients: 419
22. Profiles and Clinical Significance of HBsAg Titer in Patients Receiving Peginterferon Alfa-2a plus Ribavirin for the Treatment of Dual Chronic Infection with Hepatitis B and C Viruses: 421
23. Dynamic changes of precore and basal core promoter mutations in HBeAg-positive chronic hepatitis B patients receiving interferon therapy: 341
24. Androgen pathway stimulates MicroRNA-216a transcription to suppress the tumor suppressor in lung cancer-1 gene in early hepatocarcinogenesis
25. Determinants of Spontaneous Surface Antigen Loss in Hepatitis B E Antigen–Negative Patients With A Low Viral Load
26. In Memoriam: Dr. Ding‐Shinn Chen, 1943‐2020
27. Identification of androgen response elements in the enhancer I of hepatitis B virus: A mechanism for sex disparity in chronic hepatitis B#
28. Hepatitis B virus X protein enhances the transcriptional activity of the androgen receptor through c-Src and glycogen synthase kinase-3β kinase pathways#
29. A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkinʼs lymphoma: A randomized trial
30. Hepatitis B viral factors in HBeAg-Negative carriers with persistently normal serum alanine aminotransferase levels
31. Baseline Level of Hepatitis B Core Antibody Predicts Spontaneous Hepatitis B e Antigen (HBeAg) Seroconversion in HBeAg‐Positive Children With a Normal Alanine Aminotransferase Level
32. Expression of Metastatic Tumor Antigen 1 Splice Variant Correlates With Early Recurrence and Aggressive Features of Hepatitis B Virus–Associated Hepatocellular Carcinoma
33. Lymphocyte Antigen 6 Complex, Locus C+ Monocytes and Kupffer Cells Orchestrate Liver Immune Responses Against Hepatitis B Virus in Mice
34. Smoking and Hepatitis B Virus–Related Hepatocellular Carcinoma Risk: The Mediating Roles of Viral Load and Alanine Aminotransferase
35. Androgen Receptor Enhances Hepatic Telomerase Reverse Transcriptase Gene Transcription After Hepatitis B Virus Integration or Point Mutation in Promoter Region
36. Targeting histone deacetylase 4/ubiquitin‐conjugating enzyme 9 impairs DNA repair for radiosensitization of hepatocellular carcinoma cells in mice
37. Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma
38. Reply
39. Discovery of novel src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinoma
40. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads
41. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load
42. Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy
43. A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: A randomized trial
44. Allelic loss of chromosome 4q21 ≍ 23 associates with hepatitis B Virus—related hepatocarcinogenesis and elevated alpha-fetoprotein
45. Origin of serum hepatitis B virus in acute exacerbation: Comparison with HBV in the liver and from other exacerbation
46. Allelic loss of chromosome 4q21?23 associates with hepatitis B virus-related hepatocarcinogenesis and elevated alpha-fetoprotein
47. A forgotten population with chronic hepatitis C infection: Subjects coinfected with hepatitis B virus
48. Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk
49. Reply
50. Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.